As the UK investigates systemic mental health failures, CCHR's traveling exhibit reveals the human cost of coercive ...

The Dark Genome Therapeutics market, valued at USD 2,155.7 million in 2024, is expected to register robust revenue CAGR of 23.8%.Request free copy of this report: 01, 2025 - Integration of AI and ...

This whole thing only works if both of you feel seen and communicate. Don’t skip the conversation part, even if it might be ...

Find out how has live betting affected the sports industry, reshaping betting habits and industry operations like never ...

Attendees learned the raw and shocking facts about psychiatry and its role in the creation and support of apartheid. The ...

It's not every day that you don't feel at home in your home. A real estate company will be giving payouts to one group of people for that very reason.

Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“ Cybin ” or the“ Company ”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing ...

This financing represents a major inflection point for Cybin and supports our position as a leader within our sector,” said Doug Drysdale, Chief Executive Officer of Cybin. "High Trail Capital is an ...

4. Commercial organisation with an interest in any topic related to heath care or medical research ...